These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7456015)

  • 21. [Chronic acquired hepatocerebral degeneration: the role of manganese and treatment by endovascular occlusion of a porto-systemic shunt].
    Condat B; Dusoleil A; Bernardeau M; Roche A; Pelletier G; Buffet C
    Gastroenterol Clin Biol; 1999 Feb; 23(2):268-70. PubMed ID: 10353021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transjugular intrahepatic portosystemic shunt: indications, prevention and management of complications].
    Wu X; Cao J; Wu X
    Zhonghua Wai Ke Za Zhi; 1995 Dec; 33(12):762-4. PubMed ID: 8762560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing pattern of portasystemic shunt surgery.
    van der Vliet JA; de Visser E; Buskens FG
    Eur J Surg; 1995 Dec; 161(12):877-80. PubMed ID: 8775628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peripheral gangrene following iatrogenic ergotism].
    Pigrau Serrallach C; Llorens Forés A; Arnau de Bolós JM; Clotet Sala B; Pahissa Berga A
    Med Clin (Barc); 1981 Jun; 77(2):85-6. PubMed ID: 7321634
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pulmonary hypertension associated with portal hypertension. Apropos of 2 cases].
    Mirode A; Tribouilloy C; Boulanger J; Adam MC; Trojette F; Lesbre JP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1647-50. PubMed ID: 8746001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ergotism-like reaction to drug- and nicotine abuse].
    Jecht E
    Z Hautkr; 1983 Jan; 58(1):33-8. PubMed ID: 6829195
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute ergotism with a therapeutic association josamycin/ergotamine (author's transl)].
    Grolleau JY; Martin M; de la Guerrande BD; Barrier J; Peltier P
    Therapie; 1981; 36(3):319-21. PubMed ID: 7292409
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute ergotism caused by dihydroergotamine-triacetyloleandomycin association].
    Franco A; Bourlard P; Massot C; Lecoeur J; Guidicelli H; Bessard G
    Nouv Presse Med; 1978 Jan; 7(3):205. PubMed ID: 307229
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemolysis after transjugular intrahepatic portosystemic shunting: the naked stent syndrome.
    Conn HO
    Hepatology; 1996 Jan; 23(1):177-81. PubMed ID: 8550038
    [No Abstract]   [Full Text] [Related]  

  • 30. Liver transplantation in patients with a previous portasystemic shunt.
    Moreno-González E; Gomez R; Bonet H; Garcia I; Gonzalez-Pinto I; Loinaz C; Maffettone V
    Hepatogastroenterology; 1993 Dec; 40(6):593-5. PubMed ID: 8119646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nursing for patients with portal hypertension after transjugular intrahepatic portosystemic shunt (TIPS)].
    Wang YF; She MP; Fan YA
    Zhonghua Hu Li Za Zhi; 1995 Feb; 30(2):74-6. PubMed ID: 7664376
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thrombocytopenia and surgical treatment].
    Paquet KJ
    Dtsch Med Wochenschr; 1990 Feb; 115(7):277. PubMed ID: 2302998
    [No Abstract]   [Full Text] [Related]  

  • 33. Transjugular intrahepatic portosystemic stent shunt.
    Jalan R; Redhead DN; Hayes PC
    Natl Med J India; 1995; 8(1):15-21. PubMed ID: 7696939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ergotism: a minor form resulting from the association of dihydroergotamine with doxycycline hydrochloride. Capillaroscopic study].
    Amblard P; Reymond JL; Franco A; Beani JC; Carpentier P; Lemonnier D; Bessard G
    Nouv Presse Med; 1978 Dec; 7(45):4148-9. PubMed ID: 745947
    [No Abstract]   [Full Text] [Related]  

  • 35. Portal-systemic encephalopathy (PSE) after transjugular intrahepatic portal-systemic stent-shunts (TIPS).
    Conn H
    Ital J Gastroenterol; 1993; 25(7):397-9. PubMed ID: 8280903
    [No Abstract]   [Full Text] [Related]  

  • 36. [The clinical efficacy and complications of the transjugular intrahepatic portosystemic shunt-stent].
    Santolaria Piedrafita S; Salvador Milian E; Barrao Yoldi E; Ducons García J; Oscariz Gonzálvez J; Ariño Calve I; Fernández Gómez J; de Gregorio Ariza MA; Barrao Comps F
    Rev Clin Esp; 1995 Sep; 195(9):609-13. PubMed ID: 7481003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombosed mesocaval shunt: salvage by mechanical thrombolysis. Case report and review of the literature.
    Baijal SS; Mohan S; Singh JR; Verma A
    Cardiovasc Intervent Radiol; 2008 Jul; 31 Suppl 2():S161-5. PubMed ID: 18026793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of refractory hydrothorax with intrahepatic portosystemic shunt in the course of primary biliary cirrhosis].
    Bechade D; Blanc JF; Lescene R; Drouillard J; Oddes B
    Gastroenterol Clin Biol; 1998; 22(8-9):743-5. PubMed ID: 9823569
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transjugular intrahepatic portasystemic stent shunt (TIPSS). Indications and postoperative management].
    Theilmann L; Sauer P
    Radiologe; 1994 Apr; 34(4):164-7. PubMed ID: 8052706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemolysis associated with intrahepatic percutaneous portosystemic shunt].
    Pérez Roldan F; Rodríguez Laíz JM; Casado M; Bañares R; Lago M; Clemente G; Echenagusía A; Camúñez F; Cos E
    Gastroenterol Hepatol; 1995 Apr; 18(4):169-71. PubMed ID: 16541562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.